MiltonPackerMD

Summary

• Milton Packer, MD, is an internationally recognized clinical investigator who has made many seminal contributions to the field of heart failure, both in understanding its mechanisms and defining its rational management.
  
  Dr. Packer’s work has spanned nearly 40 years and has been strongly supported by numerous investigator-initiated grants from the NIH and from industry.
  
  His research established the cornerstone of the current modern treatments for heart failure, for which he was the recipient of the Lewis Katz lifetime achievement award in cardiovascular research.
  
  Dr. Packer is also widely recognized for his outstanding leadership abilities, having led the Division of Circulatory Physiology at Columbia University for 12 years, which he built into the nation’s most outstanding research group devoted to heart failure. He has been the principal investigator of more than 15 large international multicenter trials.
  
  Dr. Packer has served frequently as a member of government advisory committees, study sections, task forces or Data and Safety Monitoring Boards for the NIH. He served as a member of the Cardiac and Renal Drugs Advisory Committee to the US Food and Drug Administration from 1986-1992 and then as its Chair from 1997-2001, and he continues to serve on various FDA advisory committees.
  
  Dr. Packer was President of the Heart Failure Society of America from 2000-2002 and has served on numerous guidelines and standards committees for the American Heart Association and American College of Cardiology. He has received many teaching awards and has mentored dozens of young clinical investigators, many of whom have become leaders in basic and clinical research.
  
  Dr. Packer spent most of his career in New York City, where he was the Dickinson Richards Professor and Chief of the Division of Circulatory Physiology at Columbia University. From 2004 until 2015, he was Professor and Chair of the Department of Clinical Sciences at the University of Texas Sou